Here, diabetic mice showed activation of NF-κB and increased expression of IL-6 and TNF-α, we found kirenol could inhibit NF-κB activation as well as gene expression of IL-6 and TNF-α induced by diabetes. Here, NFKB1 is linked to diabetes mellitus.